GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

131,000 shares €700 885.51 On the buy side: 2,256 On the sell side: 2,012 Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) July 9, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial. During this same period, the number of trades were: ABOUT GENFIT and our con ...